In patients who develop vasculitis while taking propylthiouracil, a specific antibody called p-ANCA is often present in the blood and helps confirm the diagnosis when symptoms like joint pain and skin changes are also present.
Claim Context
Perinuclear ANCA (p-ANCA) positivity is commonly detected in patients with propylthiouracil-induced vasculitis, serving as a diagnostic marker in the context of compatible clinical symptoms.
“Perinuclear ANCA (p-ANCA) is almost always positive in these patients... The laboratory tests showed... perinuclear ANCA (p-ANCA): 69 units/mL (normal up to 1.4).”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
The pooled sensitivity and specificity of p-ANCA for diagnosing propylthiouracil-induced vasculitis compared to other causes of vasculitis.
A systematic review and meta-analysis of all published studies reporting p-ANCA test results in patients with confirmed PTU-induced vasculitis and control groups with other vasculitides or drug-induced syndromes, calculating pooled sensitivity, specificity, and likelihood ratios.
The proportion of Graves' disease patients on PTU who develop p-ANCA positivity before or during vasculitis symptoms.
A prospective cohort of 1,000 Graves' disease patients on PTU, with monthly p-ANCA testing and symptom screening for 24 months, to determine incidence, timing, and predictive value of p-ANCA elevation.
Whether p-ANCA positivity is more frequent in patients with PTU-induced vasculitis than in those with vasculitis from other causes.
A multicenter case-control study comparing 100 patients with PTU-induced vasculitis to 100 with other forms of ANCA vasculitis, assessing p-ANCA titers, MPO specificity, and clinical features at diagnosis.
That p-ANCA positivity can be detected in a patient with vasculitis symptoms during PTU treatment.
A detailed case report of a patient with Graves' disease on PTU who develops vasculitis symptoms and has elevated p-ANCA levels, with confirmation by immunofluorescence and ELISA.